Concepedia

Xingmei Liang

XL

6

Publications

215

Citations

6

H-Index

2017

Active since

Affiliations

Tianjin Medical University General Hospital(Current)

Tianjin Medical University Cancer Institute and Hospital

Tianjin Medical University

Xingmei Liang is an author at Tianjin Medical University General Hospital specializing in tumor biology, lung cancer, and oncology.

Top concepts

Publications per year

2017–2021

6

Publications

6

Targeting the <scp>EMT</scp> transcription factor Snail overcomes resistance to osimertinib in <scp><i>EGFR</i></scp>‐mutant non‐small cell lung cancer

Qiong Qin, Xiaoqing Li, Xingmei Liang et al. · Thoracic Cancer · 2021 · 56 citations · Full text

<scp>CDK4/6</scp> inhibitor palbociclib overcomes acquired resistance to third‐generation <scp>EGFR</scp> inhibitor osimertinib in <scp>non‐small</scp> cell lung cancer (<scp>NSCLC</scp>)

Qiong Qin, Xiaoqing Li, Xingmei Liang et al. · Thoracic Cancer · 2020 · 46 citations · Full text

Rictor regulates the vasculogenic mimicry of melanoma <i>via</i> the <scp>AKT</scp>‐<scp>MMP</scp>‐2/9 pathway

Xingmei Liang, Ran Sun, Xiulan Zhao et al. · Journal of Cellular and Molecular Medicine · 2017 · 44 citations · Full text

Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors <i>via</i> the transporter ASCT2

Ping Zhou, Xingmei Liang, Ce Zhou et al. · Journal of Materials Chemistry B · 2019 · 32 citations

Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer

Xingmei Liang, Qiong Qin, Boning Liu et al. · Acta Pharmacologica Sinica · 2021 · 22 citations · Full text

, , +10

Rows per page

1–5 of 6